Dosage Adjustment - Pre Lecture Flashcards

1
Q

What is the effects of cardiac failure on absorption?

A

Mucosal edema and reduced GI blood flow will alter absorption of some drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the effects of cardiac failure on distribution?

A
  1. Decreased tissue perfusion and altered fraction of drug distributed the between plasma and tissue compartment
  2. Usual dose can elevate plasma concentration to toxic

Quinidine or lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the effects of cardiac failure on elimination?

A
  1. Decreased hepatic perfusion accompanies reduced cardiac output
  2. Reduces renal elimination of drug from reduced filtration, increasing toxicity (ahminoglycosides and digoxin)
  3. High ER drugs (lidocaine) show limited perfusion limited clearance therefore increase concentrations at low cardiac output
  4. Decreased hepatic metabolic capacity by tissue hypoxia and cellular damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the major route of elimination for parent drugs and metabolites?

A

Renal excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does renal disease affect absorption?

A
  1. Urea is cleaved therefore gastric pH increases
  2. Ammonia and buffers are yielded
  3. Nephrotic syndrome
  4. Reduction of ferrous iron absorption and other drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is nephrotic syndrome?

A

Resistance to oral diuretics and malabsorption of loo[ diuretics through the edematous intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does renal disease affect distribution?

A
  1. Accumulation of acidic substances that compete with drug binding sites (albumin)
  2. PK of drugs are altered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the exception of drug PK changes due to renal disease?

A

Phenytoin, therapy is guided by plasma concnetration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe phenytoin properties during renal impairment?

A

Drug protein binding reduction by competition of accumulated molecules normally cleared by kidney (albumin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does renal disease affect metabolism?

A

CYP3A4 of phase 2 are reduced, phase 2 is less affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does renal disease affect excretion?

A
  1. Filtration and secretion fall into step
  2. Excretion is related to GFR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the main site of metabolism?

A

Liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the solution to liver disease’s unpredictable effects on drug handling?

A
  1. Unsuccessful in determining the correlation between PK of drugs and liver function
  2. Close clinical monitoring is better
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does liver disease affect absorption?

A
  1. Portal hypertension and hypoalbuminia from mucosal edema
  2. anastomoses allow bypassing of first-metabolism increasing bioavailability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does liver disease affect distribution?

A

Reduced albumin binding -> increased apparent Vd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does liver disease affect metabolism?

A

Phase I drug metabolism mediated by CYP450 drug is generally reduced

17
Q

What are examples of DDIs?

A
  1. Drug drug
  2. Food drug
  3. Chemical drug
18
Q

What is a DDI?

A

Modification of action caused by food or drugs

19
Q

What is unintentional DDI?

A

Produce adverse reactions in the patient

20
Q

What is intentional DDI?

A

Provide improved therapeutic response or decrease adverse drug effects

21
Q

What are the mechanisms of DDI?

A

pharmdynamics
Phamocokinetics

22
Q

What is PD DDI?

A

Directly at the drug target level or at the level of downstream signaling pathways or by cross-talking pathways

23
Q

What is PK DDI?

A

Changes in drug exposure parameters (AUC changes)

24
Q

What is the common approach to deal with DDI?

A

Avoid the interacting combinations by choosing alternative drugs

25
Q

In what cases would alternative therapies not work?

A
  1. Alterations in dose
  2. Treatment
    3/ Additional monitoring
26
Q

What makes a drug susceptible to DDI?

A
  1. Low TI
  2. Nonlinear PK
  3. Steep dose response curve
  4. Enzyme inhibiting or inducing properties
  5. Genetic variations in drug metabolizing enzymes and/or transporters